Whanin Pharmaceutical (016580.KS) traded down -1.18 % during a 24 hours period ending at 12:49 AM Central Europe on Wednesday 28th. One Whanin Pharmaceutical stock can currently be bought for about KRW 10,230 on popular exchanges. Current supply of Whanin Pharmaceutical stocks is 18.7 mn. Whanin Pharmaceutical has a current market capitalization of KRW 188.5 bn and approximately KRW 253.9 mn worth of Whanin Pharmaceutical was traded on exchanges in the last 24 hours. Since last month end, Whanin Pharmaceutical has traded -0.88 % down. Simple moving average of last 200 days is at KRW 10,396. The highest price of past 52 weeks was recorded at KRW 12,140 on 05/04/2026. 52 weeks low was at KRW 9,160 on 06/26/2026.
Here is how related stocks have performed in the past 24 hours:
Jetema (216080.KQ) traded down -2.31 % and now trades at KRW 6,030. Current market capitalisation for Jetema is KRW 220.4 bn.
Brils (468670.KQ) traded up 20.65 % and now trades at KRW 20,450. Current market capitalisation for Brils is KRW 220 bn.
Philenergy (378340.KQ) traded down -3.6 % and now trades at KRW 10,470. Philenergy has a market capitalisation of KRW 220.1 bn.
Nextbiomedical (389650.KQ) traded down -0.18 % and now trades at KRW 28,000. Current market capitalisation for Nextbiomedical is KRW 224.7 bn. Current price/earnings ratio for Nextbiomedical is 1,034.83.
About Whanin Pharmaceutical
Whanin Pharmaceutical Co., Ltd. is a health care company based in Seoul, Korea. The company specializes in manufacturing medical drugs used to treat various health disorders, including mental disorders, fever, liver disorders, and alcohol addiction. They also produce antibiotics and multivitamins. You can find more information about their products and services on their website, www.whanin.co.kr . They are listed on the Korea Exchange Stock Market.